Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:46 AM UTC
| NCT Number | NCT06319027 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-Wildtype |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 12 sites in the US |
| Sponsor | ECOG-ACRIN Cancer Research Group |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06319027 is currently recruiting participants. This clinical trial study for glioblastoma, idh-wildtype is actively seeking new participants at 12 locations across the United States. The study is sponsored by ECOG-ACRIN Cancer Research Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06319027 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06319027 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.